Low-dose low–molecular-weight heparin is anti-inflammatory during venous thrombosis

The Pharmacological Basis of Therapeutics

1976 • 8,675 citations

A dual receptor system is required for basic fibroblast growth factor activity

1991 • 589 citations

Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation

1993 • 499 citations

Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues

1983 • 419 citations

Prevention of Venous Thromboembolism

1995 • 359 citations

Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies.

1980 • 337 citations

Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein.

1995 • 236 citations

Heparin and modified heparin inhibit complement activation in vivo.

1992 • 223 citations

Heparin and Related Polysaccharides

1992 • 217 citations

Venous Thrombosis–Associated Inflammation and Attenuation With Neutralizing Antibodies to Cytokines and Adhesion Molecules

1995 • 181 citations

Transvascular flux and tissue accrual of Evans blue: effects of endotoxin and histamine.

1988 • 116 citations

Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis

1997 • 111 citations

Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in Rabbitsa

1989 • 108 citations

Hematology : clinical and laboratory practice

1993 • 100 citations

Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis

1983 • 90 citations

Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238)

1978 • 86 citations

Plasma volume estimation in severely ill infants and children using a simplified Evans blue method

1977 • 80 citations

Homogeneous, structurally defined heparin-oligosaccharides with low anticoagulant activity inhibit the generation of the amplification pathway C3 convertase in vitro.

1988 • 70 citations

Heparin Decreases Ischemia-Reperfusion Injury in Isolated Canine Gracilis Model

1988 • 70 citations

Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes. Effects of histidine-rich glycoprotein

1989 • 50 citations

Neutrophils Are the Initial Cell Type Identified in Deep Venous Thrombosis Induced Vein Wall Inflammation

1996 • 49 citations

Anti-Inflammatory Effects of Heparin and its Derivatives Inhibition of Complement and of Lymphocyte Migration

1992 • 40 citations

Heparin, Its Fractions, Fragments and Derivatives Some Newer Perspectives

1985 • 29 citations

Interactions of Heparins in the Vascular Environment

1993 • 26 citations

Heparin in Burns

1975 • 23 citations

ENOXAPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN SUPPRESSES PROTHROMBIN ACTIVATION MORE EFFECTIVELY THAN UNFRACTIONATED HEPARIN IN PATIENTS TREATED FOR VENOUS THROMBOEMBOLISM

1997 • 20 citations

Heparin, Monocytes, and Procoagulant Activity

1990 • 15 citations

Examination of the Utility of the Rat as an Animal Model for Human Anticoagulation

1987 • 14 citations

Antithrombotic therapy

2012 • 5 citations

Deleted Work

1955 • 0 citations